Igyxos
1 known investors
Find your way into Igyxos
Sign up to see every warm intro you have to Igyxos
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Igyxos team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Igyxos Biotherapeutics develops monoclonal antibody therapeutics aimed at treating infertility by boosting the activity of Follicle Stimulating Hormone (FSH) in reproduction. The company targets improved reproductive health outcomes for men and women struggling with infertility.
Investors · 1
Frequently asked questions
- What does Igyxos do?
- Igyxos Biotherapeutics develops monoclonal antibody therapeutics aimed at treating infertility by boosting the activity of Follicle Stimulating Hormone (FSH) in reproduction. The company targets improved reproductive health outcomes for men and women struggling with infertility.
- Who are Igyxos's investors?
- Igyxos's investors include GO Capital.
